FDA and DOJ Seize $700k Worth of Illegal E-Cigarettes

Regulations by 2FIRSTS.ai
May.02.2024
FDA and DOJ Seize $700k Worth of Illegal E-Cigarettes
FDA and DOJ collaborate to seize over $700,000 worth of illegal e-cigarette products from a California warehouse, targeting multiple distributors.

According to an announcement released by the FDA on April 30, the FDA, in collaboration with the DOJ, announced a joint operation with the U.S. Marshals Service to seize illegal e-cigarette products valued at over $700,000. This batch of e-cigarettes was seized at a warehouse in Alhambra, California, believed to be owned by multiple California distributors. The seized products mainly consisted of flavored e-cigarette products, including disposable e-cigarettes from brands such as Puff Bar/Puff, Elf Bar/EB Design, Esco Bar, Kuz, Smok, and Pixi.

 

This operation marks the first joint effort between the FDA, DOJ, and law enforcement agencies to crack down on illegal tobacco products. A total of over 45,000 illegal e-cigarettes were seized, valued at approximately $703,000.

 

This seizure initially targeted products held and sold by MDM Group, a distributor operating under the name Eliquidstop.com. In May 2023, the FDA issued a warning letter to MDM, initiating an investigation into their sale or distribution of illegal, flavored e-cigarette products. In January 2024, the FDA conducted a second inspection of the company and found that they were still selling illegal products on a commercial scale. During the raid on MDM facilities, authorities received information that several other companies may be connected to the seized illegal e-cigarettes. On April 5, 2024, the Los Angeles Federal Prosecutor's Office on behalf of the FDA filed a civil forfeiture lawsuit in the United States Central District Court, alleging that the seized products violated federal law.

 

Jill Atencio, Acting Director of the FDA Compliance Office, stated, "Removing illegal tobacco products from the supply chain is one of our many enforcement tools. The FDA will continue to take appropriate actions against illegal tobacco products, as well as those involved in manufacturing, distributing, importing, or selling these illegal e-cigarette products, especially those that are appealing to young people."

 

As of April 2024, the FDA has sent approximately 670 warning letters to companies that manufacture and/or distribute illegal e-cigarette products, and has issued over 550 warning letters to retailers selling illegal e-cigarettes. The agency has filed civil penalties complaints against more than 50 e-cigarette manufacturers and over 100 retailers, and has filed permanent injunction complaints against 7 e-cigarette manufacturers.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.